Reishi-MRL supports the body´s normal cellular immune system.*

While Mycology Research Labs Reishi-MRL (Ganoderma lucidum) powder is not an extract of Ganoderma lucidum, the powder does contains both mycelium and primordia (young fruit body) cultivated into a biomass that is grown on a sterilized (autoclaved) substrate.

This cultivation process ensures the powder is free from contamination by other fungi and that pesticides and heavy metals are absent. The cultivation system is proprietary, allowing for standardized production of Ganoderma lucidum. The powder biomass is then sealed in plastic containers.

The Reishi-MRL biomass contains mycelium and primordia (young fruiting body) of the respective mushroom. In comparison to Resihi extracts, biomass has the advantage of no unwanted shift of effect which happens with extracts or concentrates, including lyophilisation, and thus the activity of the product corresponds with the source mushroom, while being further intensified by utilizing the entire mycelium.

Mycology Research Labs Ganoderma lucidum is processed under the same rigorously controlled conditions that are applied to the manufacture of a conventional pharmaceutical. This ensures that each tablet contains 500 mg of standardized Ganoderma lucidum product.

The tablets are film coated to protect them from moisture, thus preserving the quality of the product and ensuring a long shelf life.

After passing quality control testing the tablets are released for use. The choice of additives used in manufacture renders these tablets suitable for Kosher or vegetarian use.